The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort-Reference-Cited by-同舟云学术

The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort

Published:2017-03-01 Issue:16 Volume:8 Page:26789-26801
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ness Nora¹,Andersen Sigve²³,Khanehkenari Mehrdad Rakaee¹,Nordbakken Cecilie V.⁴,Valkov Andrej⁴,Paulsen Erna-Elise²³,Nordby Yngve²⁵,Bremnes Roy M.²³,Donnem Tom²³,Busund Lill-Tove¹⁴,Richardsen Elin¹⁴

Affiliation:

1. Department of Medical Biology, UiT The Arctic University of Norway, N-9037 Tromso, Norway

2. Department of Clinical Medicine, UiT The Arctic University of Norway, N-9037 Tromso, Norway

3. Department of Oncology, University Hospital of North Norway, N-9038 Tromso, Norway

4. Department of Clinical Pathology, University Hospital of North Norway, N-9038 Tromso, Norway

5. Department of Urology, University Hospital of North Norway, N-9038 Tromso, Norway

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence of Programmed Death-Ligand 1 Expression in a Highly Inflammatory Prostate: A Literature Review and Our Experience;Cureus;2024-08-25

2. Pembrolizumab for metastatic castration-resistant prostate cancer: trials and tribulations;Expert Opinion on Biological Therapy;2024-01-31

3. Comprehensive Analysis of DNA Methyltransferases Expression in Primary and Relapsed Ovarian Carcinoma;Cancers;2023-10-11

4. Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer;Current Treatment Options in Oncology;2023-08-10

5. PD-L1 overexpression in prostate cancer: a potential targeted therapy;Bali Medical Journal;2023-07-31